A detailed history of Rothschild Investment LLC transactions in Savara Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 350 shares of SVRA stock, worth $952. This represents 0.0% of its overall portfolio holdings.

Number of Shares
350
Previous 60 483.33%
Holding current value
$952
Previous $254,000 323.23%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$2.94 - $4.07 $852 - $1,180
290 Added 483.33%
350 $1.08 Million
Q3 2024

Oct 18, 2024

BUY
$3.96 - $5.07 $237 - $304
60 New
60 $254,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $310M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.